AC Immune SA (ACIU)

AC Immune Statistics

Total Valuation

AC Immune has a market cap or net worth of $302.56 million. The enterprise value is $214.68 million.

Market Cap	302.56M
Enterprise Value	214.68M

Important Dates

The last earnings date was Thursday, April 30, 2026, before market open.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	n/a

Share Statistics

AC Immune has 99.20 million shares outstanding. The number of shares has increased by 0.43% in one year.

Current Share Class	99.20M
Shares Outstanding	99.20M
Shares Change (YoY)	+0.43%
Shares Change (QoQ)	-2.37%
Owned by Insiders (%)	5.83%
Owned by Institutions (%)	6.18%
Float	38.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	65.56
Forward PS	7.58
PB Ratio	7.66
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	46.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.87, with a Debt / Equity ratio of 0.14.

Current Ratio	0.87
Quick Ratio	0.83
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-318.22

Financial Efficiency

Return on equity (ROE) is -104.83% and return on invested capital (ROIC) is -59.16%.

Return on Equity (ROE)	-104.83%
Return on Assets (ROA)	-23.06%
Return on Invested Capital (ROIC)	-59.16%
Return on Capital Employed (ROCE)	-142.30%
Weighted Average Cost of Capital (WACC)	13.17%
Revenue Per Employee	$37,830
Profits Per Employee	-$676,680
Employee Count	122
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +77.33% in the last 52 weeks. The beta is 1.65, so AC Immune's price volatility has been higher than the market average.

Beta (5Y)	1.65
52-Week Price Change	+77.33%
50-Day Moving Average	2.95
200-Day Moving Average	2.90
Relative Strength Index (RSI)	52.30
Average Volume (20 Days)	288,100

Short Selling Information

The latest short interest is 2.93 million, so 6.01% of the outstanding shares have been sold short.

Short Interest	2.93M
Short Previous Month	2.96M
Short % of Shares Out	6.01%
Short % of Float	n/a
Short Ratio (days to cover)	11.85

Income Statement

In the last 12 months, AC Immune had revenue of $4.62 million and -$82.55 million in losses. Loss per share was -$0.82.

Revenue	4.62M
Gross Profit	-65.74M
Operating Income	-80.14M
Pretax Income	-82.55M
Net Income	-82.55M
EBITDA	-78.42M
EBIT	-80.14M
Loss Per Share	-$0.82

Balance Sheet

The company has $93.25 million in cash and $5.37 million in debt, with a net cash position of $87.88 million or $0.89 per share.

Cash & Cash Equivalents	93.25M
Total Debt	5.37M
Net Cash	87.88M
Net Cash Per Share	$0.89
Equity (Book Value)	39.31M
Book Value Per Share	0.40
Working Capital	-15.20M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	1.76M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-1,736.39%
Pretax Margin	-1,788.74%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AC Immune does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.43%
Shareholder Yield	-0.43%
Earnings Yield	-27.29%
FCF Yield	n/a

Analyst Forecast

The average price target for AC Immune is $8.00, which is 162.30% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	162.30%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	101.22%
EPS Growth Forecast (5Y)	-2.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a